文献速递临床试验与 GCP

40赫兹视听觉刺激诱导伽马振荡治疗卒中后急性期肢体运动康复:前瞻性随机对照试验研究方案

Gamma oscillations induced by 40-Hz visual-auditory stimulation for the treatment of acute-phase limb motor rehabilitation after stroke: study protocol for a prospective randomized controlled trial.
PubMed 文献 · Trials · 2024-04-26

本研究为前瞻性、随机、双盲临床试验,旨在验证40赫兹视听觉刺激诱导伽马振荡治疗卒中后上肢功能障碍的安全性与有效性,并探索突触相关基因和神经网络连接等机制。主要疗效终点为运动功能变化,次要终点包括运动诱发电位、脑血流动力学变化、神经网络连接及突触相关基因改变。安全性评价包括主要不良事件、全因死亡和光敏性癫痫,评估在基线、14天治疗结束后及治疗后3个月和6个月随访时进行。

要点

  • 试验为前瞻性随机双盲对照,比较40赫兹视听觉刺激与随机匹配频率视听觉刺激。
  • 主要疗效终点为运动功能变化,次要终点含运动诱发电位和脑血流动力学等。
  • 安全性评价包括主要不良事件、全因死亡和光敏性癫痫。

核心结论

  • 本研究将评估40赫兹视听觉刺激诱导伽马振荡治疗急性脑卒中后上肢功能障碍的安全性和有效性,并探索突触相关基因和神经网络连接等潜在机制。

研究设计与样本

  • 前瞻性、随机、双盲临床试验,所有入组患者随机分配至两组。
  • 实验组接受40赫兹视听觉刺激干预,对照组接受随机匹配频率的视听觉刺激干预。
  • 评估在基线、14天治疗结束后及治疗后3个月和6个月随访时进行。

关键数值与推荐

  • 主要疗效终点为运动功能变化。
  • 次要疗效终点包括运动诱发电位、脑血流动力学变化、神经网络连接及突触相关基因改变。
  • 安全性评价包括主要不良事件、全因死亡和光敏性癫痫。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The incidence of hemiparetic limb dysfunction reaches 85% in stroke patients, emerging as a critical factor influencing their daily lives. However, the effectiveness of current rehabilitation treatments is considerably limited, particularly in patients with upper extremity impairment. This study aims to conduct a prospective clinical trial to validate the safety and effectiveness of gamma oscillations induced by 40-Hz visual-auditory stimulation in treating post-stroke upper limb dysfunction and to explore the relevant mechanisms. METHODS: This trial is a prospective, randomized controlled, double-blind study. All enrolled patients were randomly assigned to two groups. The experimental group received intervention through 40-Hz visual-auditory stimulation, while the control group underwent intervention with randomly matched visual-auditory stimulation frequencies. The primary efficacy endpoint is the change in motor function. Secondary efficacy endpoints include motor-evoked potentials, cerebral hemodynamic changes, neural network connectivity, and alterations in synaptic-related genes. Safety evaluation included major adverse events, all-cause mortality, and photosensitive epilepsy. Assessments will be conducted at baseline, after a 14-day treatment period, and during subsequent follow-up visits (at 3 and 6 months) post-treatment. The differences between the two groups will be compared. DISCUSSION: This study will evaluate the safety and efficacy of gamma oscillations induced by 40-Hz visual-auditory stimulation in treating patients with upper extremity dysfunction after an acute cerebral stroke. Concurrently, we will explore potential mechanisms, including changes in synaptic-related genes and neural network connectivity. This trial is expected to provide evidence for the effectiveness of this new technique in treating upper extremity dysfunction after a stroke and improving patients' quality of life. TRIAL REGISTRATION: The study protocol has been registered with the Chinese Clinical Trial Registry (ChiCTR) under registration number ChiCTR2300076579 on October 12, 2023.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Fu W, Yu X, Lai M, et al. Gamma oscillations induced by 40-Hz visual-auditory stimulation for the treatment of acute-phase limb motor rehabilitation after stroke: study protocol for a prospective randomized controlled trial. Trials. 2024. PMID: 38671516. doi:10.1186/s13063-024-08121-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。